These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner. Furusho M; Ishii A; Bansal R J Neurosci; 2017 Mar; 37(11):2931-2946. PubMed ID: 28193689 [TBL] [Abstract][Full Text] [Related]
27. Salusin-α Inhibits Proliferation and Migration of Vascular Smooth Muscle Cell via Akt/mTOR Signaling. Gao S; Xu L; Zhang Y; Yu Q; Li J; Guan H; Wang X; Cheng D; Liu Y; Bai L; Wang R; Fan J; Zhao S; Liu E Cell Physiol Biochem; 2018; 50(5):1740-1753. PubMed ID: 30384378 [TBL] [Abstract][Full Text] [Related]
28. Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development. Hoch RV; Soriano P Development; 2006 Feb; 133(4):663-73. PubMed ID: 16421190 [TBL] [Abstract][Full Text] [Related]
29. Inactivation of mammalian target of rapamycin increases STAT1 nuclear content and transcriptional activity in alpha4- and protein phosphatase 2A-dependent fashion. Fielhaber JA; Han YS; Tan J; Xing S; Biggs CM; Joung KB; Kristof AS J Biol Chem; 2009 Sep; 284(36):24341-53. PubMed ID: 19553685 [TBL] [Abstract][Full Text] [Related]
30. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate. Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512 [TBL] [Abstract][Full Text] [Related]
31. Akt/eNOS and MAPK signaling pathways mediated the phenotypic switching of thoracic aorta vascular smooth muscle cells in aging/hypertensive rats. Zhang L; Xu Z; Wu Y; Liao J; Zeng F; Shi L Physiol Res; 2018 Aug; 67(4):543-553. PubMed ID: 29750880 [TBL] [Abstract][Full Text] [Related]
32. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis. Yao X; Yan C; Zhang L; Li Y; Wan Q Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625 [TBL] [Abstract][Full Text] [Related]
33. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200 [TBL] [Abstract][Full Text] [Related]
34. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1. Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503 [TBL] [Abstract][Full Text] [Related]
35. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling. Osman I; Segar L Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070 [TBL] [Abstract][Full Text] [Related]
36. FGFR1-Frs2/3 signalling maintains sensory progenitors during inner ear hair cell formation. Ono K; Kita T; Sato S; O'Neill P; Mak SS; Paschaki M; Ito M; Gotoh N; Kawakami K; Sasai Y; Ladher RK PLoS Genet; 2014 Jan; 10(1):e1004118. PubMed ID: 24465223 [TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine kinase activity is required for oxidant-induced extracellular signal-regulated protein kinase activation and c-fos and c-jun expression. Rao GN Cell Signal; 1997 Feb; 9(2):181-7. PubMed ID: 9113418 [TBL] [Abstract][Full Text] [Related]
38. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis. Hwang YJ; Park JH; Cho DH J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519 [TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition. Xie Y; Jin Y; Merenick BL; Ding M; Fetalvero KM; Wagner RJ; Mai A; Gleim S; Tucker DF; Birnbaum MJ; Ballif BA; Luciano AK; Sessa WC; Rzucidlo EM; Powell RJ; Hou L; Zhao H; Hwa J; Yu J; Martin KA Sci Signal; 2015 May; 8(376):ra44. PubMed ID: 25969542 [TBL] [Abstract][Full Text] [Related]
40. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype. Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]